Birdwatch Note
2023-01-16 07:07:25 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This references the use of young donor plasma transfusions for "rejuvenation." However, GDF-11 (the claimed anti-aging mechanism) remains incompletely understood: https://hsci.harvard.edu/aging-and-gdf11-what-we-know The FDA has strongly discouraged this practice due to potential risks and lack of proven clinical benefit: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-director-fdas-center-biologics-evaluation-and-0 https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-about-young-donor-plasma-infusions-profit
Written by A5A8561B2CB835AEB9700B78C30C197970A1179AC4847E747D932A1A3EDEA197
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1614804604440518656
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1614881994122436609
- noteId - 1614881994122436609
- participantId - A5A8561B2CB835AEB9700B78C30C197970A1179AC4847E747D932A1A3EDEA197
- noteAuthorParticipantId -
- createdAtMillis - 1673852845119
- tweetId - 1614804604440518656
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This references the use of young donor plasma transfusions for "rejuvenation." However, GDF-11 (the claimed anti-aging mechanism) remains incompletely understood: https://hsci.harvard.edu/aging-and-gdf11-what-we-know The FDA has strongly discouraged this practice due to potential risks and lack of proven clinical benefit: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-director-fdas-center-biologics-evaluation-and-0 https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-about-young-donor-plasma-infusions-profit
Note Ratings
| rated at | rated by | |
| 2023-01-16 15:43:11 -0600 | 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 | Rating Details |
| 2023-01-16 01:16:08 -0600 | 1CACFA5FD21C14A1CD458B1B26A8F86DC7F38F92EF18583AE248A879917F7571 | Rating Details |
| 2023-01-17 12:34:14 -0600 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
| 2023-01-18 22:12:56 -0600 | 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 | Rating Details |
| 2023-01-16 02:52:24 -0600 | 3F1DD4DB8D05BA76280A10854982E7A4C3F22D4446D412D1649098AEAED8A1CA | Rating Details |
| 2023-01-16 07:13:07 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
| 2023-01-16 11:48:46 -0600 | 4DF1CDFBEA3F6DE525FEEC58EEAF593D6DE2475010A316ED6876FA4CA230339A | Rating Details |
| 2023-01-16 02:01:22 -0600 | 58315A371465429D1F19A86FB136556057E1E88CD64150D6194D39356970AEAA | Rating Details |
| 2023-01-16 02:20:49 -0600 | 5F4102EBA6D52660ED205758A9D86D07B7131DDAE05EB79F2FBEC50FE2296AD1 | Rating Details |
| 2023-01-16 08:19:10 -0600 | 6EEAF9833ED86DC99609332A3B39467DB8A259AD8805A858BF0F7FAEFB599A58 | Rating Details |
| 2023-01-16 04:02:08 -0600 | 70C181B24233FF8251A370E67F314FF2678F046BCC2BD211A42D44AC787BC7DC | Rating Details |
| 2023-01-16 11:03:15 -0600 | 7583B4F04644356AFF842575CEF9C244D1869E673D976932A67B0D047FBCEABB | Rating Details |
| 2023-01-16 15:36:00 -0600 | 7640BF10DEC76014715D6ADAC18E627AF02F2F4727C33862A234189728245F6C | Rating Details |
| 2023-01-16 07:49:29 -0600 | 862E84AD6C488AB3037EAC4682346692F09F61D556BF80E01E4F8B21C28D08CA | Rating Details |
| 2023-01-16 08:03:25 -0600 | 9B3A3A0365562199849394497F8F644780E997D27185A37636D44437D359D5C3 | Rating Details |
| 2023-01-17 01:05:03 -0600 | A2EB2A373DB2FD0A406D3D3BD4DE9E9D217A3B8C8F450931CB779A0A8EC8CBD3 | Rating Details |
| 2023-01-18 21:44:28 -0600 | A69B06A49C751780B909365C60700297DA709E5A40462E959343DE2EBC12F836 | Rating Details |
| 2023-01-16 09:40:42 -0600 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
| 2023-01-19 11:23:32 -0600 | BB8C538CBEEF7510CFFFDCCBF0AF17DD295B4BE60AB52DD9DD3FDD0CA7A1282D | Rating Details |
| 2023-01-16 10:53:53 -0600 | D08095D829205610AFA96EE4745C814F88DFB5BE5B73E8468C45B69DA8E47F23 | Rating Details |
| 2023-01-19 17:31:08 -0600 | D1CDFEB48849C52540F098BEAAA1C651B672214B1A2C7EFBF53D7B4D3AA5E543 | Rating Details |
| 2023-01-16 01:32:32 -0600 | D28D83C5A016BA0F5558AF36802BF9335DFB89CB67DC7640FD00E106858E422B | Rating Details |
| 2023-01-16 01:34:14 -0600 | D35269AF0F656B0BCABE4F94496903148DD1371FDE1B830D80722F2AF21F9EFB | Rating Details |
| 2023-01-16 09:14:01 -0600 | D5A6A431C203F752BE53DD5E4049890DF3F9F01EA76DC7BDEAC3118EBA94B544 | Rating Details |
| 2023-01-16 13:32:02 -0600 | D67A9B2E52A19BB7198D4DE40C784A285187293D66D025B86E3B84BEE5FEDA79 | Rating Details |
| 2023-01-19 19:05:09 -0600 | DC414B5D3978950E24A9FC83ACBB95357A14724AF7E29720A71AA47B3AE21E41 | Rating Details |
| 2023-01-16 06:57:53 -0600 | EF91B71AF84952C56583B9F7A1542B202AC654A65DE4829A1EE8CCD9171F9D18 | Rating Details |
| 2023-01-16 03:55:04 -0600 | EFA52FDBA69D13BBA54AB25032E045B86E9298D88D3748F201DD8FE2FD3DA32A | Rating Details |
| 2023-01-21 11:52:26 -0600 | F69F2549B58ACD296B2457D21D2B400BCD1B183A912EFC99369BA3AD3C17DDB0 | Rating Details |
| 2023-01-16 18:18:14 -0600 | FA16D15DBB4FD7487BB35AA35D77E75D645385707628BA1821D01086427D7290 | Rating Details |
| 2023-01-19 18:42:08 -0600 | FDC975B0DE10391EF04A66964CEB6E76EDA9348BE6D77A18DD6B5081DA2B7AAE | Rating Details |
| 2023-01-19 15:43:49 -0600 | Rating Details | |
| 2023-01-17 22:50:46 -0600 | Rating Details | |
| 2023-01-16 15:21:12 -0600 | Rating Details | |
| 2023-01-19 20:41:36 -0600 | Rating Details | |
| 2023-01-16 14:09:41 -0600 | Rating Details | |
| 2023-01-19 12:52:30 -0600 | Rating Details | |
| 2023-01-16 13:30:54 -0600 | Rating Details | |
| 2023-01-16 09:24:36 -0600 | Rating Details | |
| 2023-01-16 09:14:01 -0600 | Rating Details | |
| 2023-01-16 07:13:07 -0600 | Rating Details | |
| 2023-01-19 11:23:32 -0600 | Rating Details | |
| 2023-01-16 06:57:53 -0600 | Rating Details | |
| 2023-01-16 04:02:08 -0600 | Rating Details | |
| 2023-01-16 08:03:25 -0600 | Rating Details | |
| 2023-01-16 09:40:42 -0600 | Rating Details | |
| 2023-01-16 15:21:12 -0600 | Rating Details | |
| 2023-01-19 20:41:36 -0600 | Rating Details | |
| 2023-01-16 01:16:08 -0600 | Rating Details | |
| 2023-01-16 14:09:41 -0600 | Rating Details | |
| 2023-01-19 12:52:30 -0600 | Rating Details | |
| 2023-01-16 02:20:49 -0600 | Rating Details | |
| 2023-01-21 11:52:26 -0600 | Rating Details | |
| 2023-01-16 03:55:04 -0600 | Rating Details | |
| 2023-01-19 19:05:09 -0600 | Rating Details | |
| 2023-01-16 15:43:11 -0600 | Rating Details | |
| 2023-01-18 22:12:56 -0600 | Rating Details | |
| 2023-01-16 11:03:15 -0600 | Rating Details | |
| 2023-01-16 13:32:02 -0600 | Rating Details | |
| 2023-01-16 07:49:29 -0600 | Rating Details | |
| 2023-01-16 01:34:14 -0600 | Rating Details | |
| 2023-01-16 02:01:22 -0600 | Rating Details | |
| 2023-01-16 13:30:54 -0600 | Rating Details | |
| 2023-01-16 15:36:00 -0600 | Rating Details | |
| 2023-01-17 12:34:14 -0600 | Rating Details | |
| 2023-01-19 15:43:49 -0600 | Rating Details | |
| 2023-01-19 17:31:08 -0600 | Rating Details | |
| 2023-01-17 22:50:46 -0600 | Rating Details | |
| 2023-01-16 02:52:24 -0600 | Rating Details | |
| 2023-01-16 11:48:46 -0600 | Rating Details | |
| 2023-01-18 21:44:28 -0600 | Rating Details | |
| 2023-01-16 18:18:14 -0600 | Rating Details | |
| 2023-01-16 09:24:36 -0600 | Rating Details | |
| 2023-01-16 01:32:32 -0600 | Rating Details | |
| 2023-01-17 01:05:03 -0600 | Rating Details | |
| 2023-01-16 10:53:53 -0600 | Rating Details | |
| 2023-01-16 08:19:10 -0600 | Rating Details | |
| 2023-01-19 18:42:08 -0600 | Rating Details |